What does it mean to be 'well led' and creating a team culture at board level?

The King's Fund
Event type: 
Board Leadership Programme

About this event

As the Care Quality Commission adds a new dimension to its regulatory framework: 'being well led', this session explores what organisations in other sectors do to ensure that their organisations are well led. Mark Phillipson, Business Operations Director, UK at Pfizer will describe what being 'well led' looks like in the context of continual change, how it has shaped their culture and how the board is focused on developing its culture, talent and leadership during times of transition.

In addition we will hear from Professor Michael West on the extensive research that he has undertaken investigating the links between the culture og highly successful teams and mortality rates.

This will be an opportunity for non-executive directors and lay members to debate the Francis recommendation of 'creating a common culture of caring' in light of the speakers' experience.

Executive colleagues are welcome to attend this event. Please contact Tracy Nottage at t.nottage@kingsfund.org.uk to book your place.

The speakers

Mark Phillipson

Mark Phillipson is currently Director of Business Operations for the UK, providing a broad range of operational support for the UK Managing Director as well as the other UK functional and commercial leaders. As well as being the commercial lead for a wide range of operational areas, the role includes a large degree of project management. The heart of the role is ensuring an aligned approach is taken across all of the UK comemercial businesses.

Prior to this role, Mark was Director of Operational Improvement and Excellence as part of a global team leading organisational or process change initiatives within Pfizer. In this role Mark brough together lean sigma and change management expertise to lead a number of high-profile projects, including running the programme office for the European re-organisation of a major business unit. Mark has been with Pfizer since 1997, starting within Pfizer's manufacturing operations where he led a number of large production units before moving into learning and development, continuous improvement and change management leadership roles.

Michael West

Michael West has spent the greater part of his career undertaking research into the factors that determine the effectiveness and innovativeness of individuals, teams and organisations at work. He has also focused on improving the wellbeing of those who work within organisations. His research has contributed to the field in three areas: innovation and creativity at work; the development of effective teams; and the links between enlightened people management and performance.

His work has stimulated research internationally and has also influenced practice in many settings. It has had particular application in the NHS (in primary health care, acute care, breast cancer care, and community mental health), with widespread use of the concepts and the associated instruments. This work has been applied in health services in many countries, including Australia, the Netherlands, Finland, Norway, Denmark, Canada and Jordan. His book Effective Teamwork has been translated into 12 different languages.

He has authored, edited or co-edited 20 books, published more than 200 articles for scientific and practicioner publications, as well as chapters in his scholarly books. He is a Fellow of the British Psychological Society, the American Psychological Association (APA), the APA Society for Industrial /Organisational Psychology, the International Association of Applied Psychologists, the British Academy of Management and a Chartered Fellow of the Chartered Institute of Personnel and Development. He is an Academian of the Academy of Social Sciences.

Michael is a Visiting Fellow at The King's Fund.